COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is 19516R107. A total of 16 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $265,000 | – | 19,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 530,400 | $7,128,000 | 1.44% |
| FRIESS ASSOCIATES LLC | 250,091 | $3,361,000 | 1.31% |
| Weil Company, Inc. | 34,968 | $470,000 | 0.27% |
| MEITAV INVESTMENT HOUSE LTD | 547,730 | $7,361,000 | 0.21% |
| VILLERE ST DENIS J & CO LLC | 242,250 | $3,255,000 | 0.18% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 69,820 | $938,000 | 0.05% |
| FNY Investment Advisers, LLC | 10,000 | $134,000 | 0.05% |
| SABBY MANAGEMENT, LLC | 17,045 | $229,000 | 0.04% |
| Sigma Planning Corp | 19,700 | $265,000 | 0.01% |
| Parallel Advisors, LLC | 5,122 | $69,000 | 0.00% |